Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Scientific Reports|July 10, 2026
TAZ mediates enhancer reprogramming blocks neuronal differentiation in glioma stem-like cellsAlessandra Audia, Mahinur Mattohti, Visweswaran Ravikumar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2021
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled TrialYukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Lancet (London, England)|January 21, 2023
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trialKohei Nakachi, Masafumi Ikeda, Masaru Konishi, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 4, 2023
Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and ConductShin Iwamoto, Kenneth Cavanaugh, Misti Malone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical TrialYukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 17, 2020
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trialYoshiaki Iwasaki, Masanori Terashima, Junki Mizusawa, et al.The Lancet. Gastroenterology & Hepatology|January 26, 2019
Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trialTakaki Yoshikawa, Masanori Terashima, Junki Mizusawa, et al.Cell Reports. Medicine|July 25, 2024
Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signalingJiying Cheng, Min Li, Edyta Motta, et al.Pageof 21